MISSION
We will own iPSC* regenerative medicine
products, services and technologies, the
building block for a variety of human cells
and tissue models for science, drug
discovery, toxicology and therapy
*induced Pluripotent Stem Cell
INNOVATION
A growing team will complete a BIRAC funded project realizing a novel cell culture medium platform replacing proteins with chemical compounds. This capability will enable development of affordable cell lines capable of meeting future therapeutic demands for safe stem cells plus provide research tools for a growing cellular ecosystem in India.
CAPABILITY
Cellagility Biomed has the capability to deliver a highly optimised safety
service, externally benchmarked with audited assurance. A guarantee of our
Safe-iPSC potential for future clinical use. If you are looking for alternative
solutions for your product development and research, talk to our cell
engineers for the latest in human cell sourcing tools and culture media.
COLLABORATION
Cellagility Biomed founded in 2018, incubated at the Bangalore Bioinnovation Centre has expanded collaboration to include both C-Camp, Centre for Cellular and Molecular Platforms and IKP Knowledge Parks. This vibrant community is further strengthened through our partnership with SDM Medical College and the Central Research Laboratory’s excellent iPSC cell banking facility.
TEAM
Dr Vishwas Kaveeshwar
Scientific & Commercial Lead
Kouichi Hasegawa
Scientific Advisory Board.jpg)
Rajiv Dixit
Science & Technical Advisor
Mr. Prashantkumar
Research Assistant
Amit Khanna
Advisory Board
Ritu
Advisory Board.jpg)
Roderick Stuart
Managing PartnerLOCATION
